ʻO ka maʻi ʻaʻai umauma hema i hui pū ʻia me nā metastases iwi lehulehu (Stage IV), ka metastasis lymph node, a me ka lymphangitis carcinomatous ma nā māmā ʻelua-03

Ma Mei 2014, ua ʻike ʻia ʻo Ms. W i ka maʻi kanesa o ka umauma hema i hele pū ʻia me nā metastases iwi lehulehu (Stage IV), lymph node metastasis, a me carcinomatous lymphangitis ma nā māmā ʻelua, a me nā pilikia ʻē aʻe.

Ma ka ʻōlelo aʻo a kāna kauka, ua hana ʻo M. Ma hope o kēia, ua lawe ʻo ia i nā steroid a me nā lāʻau ʻeha, akā ʻaʻole hiki ke hoʻopaʻa ʻia nā keʻena maʻi kanesa, a ua manaʻo nā kauka ʻaʻole ʻoi aku ma mua o ʻekolu mahina e ola ai.

Ma hope mai, ua haʻi aku kekahi hoaaloha ma ke kahua lapaʻau i ka ʻohana o Ms. W i ka mālama maʻamau no ka maʻi maʻi umauma ma Kina he ʻelima mau makahiki ola o 73.1%, akā ʻo ka immunotherapy a i ʻole ka hui pū ʻana o ka immunotherapy a me ka mālama maʻamau he ʻelima mau makahiki ola. e like me 95%. Hāʻawi kēia iā Ms. W i ka manaʻolana.

Ua aʻo ʻo Ms. W a me kona ʻohana e pili ana i ka immunotherapy i loaʻa ma Nanjing Medical University a ua hoʻoholo lākou e alualu. Ua hoʻonohonoho mua ka hui lapaʻau i ka maʻi maʻi o Ms. W a ua hōʻoia i ke kūlana o ke kino ma o nā hoʻokolohua immuno-function. Ma hope mai, ua hoʻomaka lākou i ka mālama immunotherapy. ʻO ka mea kupanaha, ʻehā mahina ma hope mai, ua hoʻomaikaʻi maikaʻi ʻia ka pōkole hanu o Ms. ʻEono mahina ma hope o ka mālama ʻana, ua hoʻemi maikaʻi ʻia kona ʻeha, ʻaʻole pono ʻo ia e noho me kahi pahu oxygen, a hiki iā ia ke hoʻōki i ka lawe ʻana i nā lāʻau ʻeha a me nā steroid. I hoʻokahi makahiki ma hope mai, ua hōʻike ʻia ke kiʻi kiʻi hahai (PET/CT) i kahi hōʻemi nui o nā maʻi kanesa i hoʻohālikelike ʻia ma mua o ka mālama ʻana. (Ke hōʻike nei nā kiʻi ma lalo nei i ka nānā ʻana ma mua o ka mālama ʻana ma ka hema a me ka nānā ʻana ma hope o ka mālama ʻana ma ka ʻākau.)

I kēia lā, ʻaʻohe maʻi maʻi ʻaʻai ʻo Ms. W a hiki iā ia ke alakaʻi i ke ola maʻamau.